CADAH CME Meeting
Tuesday, August 13, 2013
You are cordially invited attend a XOFIGO promotional speaker program:
Xofigo is indicated for the treatment of patients with castration resistant prostate cancer, symptomatic bone metastases
and no known visceral metastatic disease.
Start Time: 6:00 p.m.
Presentation Time: 6:30 p.m.
Trevisio Restaurant
6550 Bertner Ave, Suite 601
Houston, TX 77030
713-749-0400
Speaker: Robert John Amato, D.O.
The University of Texas Health Science Center at Houston
Medical School
Department of Internal Medicine
Division of Oncology
Please RSVP by August 10, 2013: cme_rsvp@yahoo.com
All medical and dental professionals are welcome. However, we cannot
accommodate any nonmedical professionals, such as spouses or guests.